Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05528562 · ClinicalTrials.gov registry record · NA
Pre-exposure Prophylaxis (PrEP) Rapid Access
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05528562 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT05528562, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of phase 1 is to determine the feasibility and acceptability of an intervention ('Rapid PrEP Access') providing people who use drugs (PWUD) one-time access to HIV self-testing at the Victory Program. Aim 1: To offer HIV self-testing to PWUD in the community through a study called 'Rapid PrEP Access'. The study will be carried out at the Victory Program. Aim 2: To determine the feasibility and acceptability of 'Rapid PrEP Access' at the Victory Program.
Interventions
- OTHER PrEP Rapid Access
- OTHER HIV self-testing
- OTHER Dried blood spot testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2023-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05528562
The ClinicalTrials.gov registry entry for NCT05528562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PrEP Rapid Access is the first listed.
NCT05528562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05528562 about?
NCT05528562 is a clinical study titled "Pre-exposure Prophylaxis (PrEP) Rapid Access". The goal of phase 1 is to determine the feasibility and acceptability of an intervention ('Rapid PrEP Access') providing people who use drugs (PWUD) one-time access to HIV self-testing at the Victory Program. Aim 1: To offer HIV self-testing to PWUD in the community through a study called 'Rapid Pr...
What is the current status of trial NCT05528562?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-04-12. Estimated completion is 2023-06-28.
What interventions are being tested in trial NCT05528562?
The interventions under investigation include: PrEP Rapid Access (OTHER), HIV self-testing (OTHER), Dried blood spot testing (OTHER).
Who is sponsoring clinical trial NCT05528562?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.